% | $
Quotes you view appear here for quick access.

Vertex Pharmaceuticals Incorporated Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • brokenideas brokenideas Oct 2, 2012 8:18 PM Flag

    Abstract Data

    Your question on how good the oral combo has to be to displace the current SOC are very good and important. I have not seen this being discussed by the analysts, and may be difficult to ever find an answer until when the drugs are approved. My bet is that it will all depend on the SVR values. if we are assuming SVRs 70% for the all oral combo, the convenience of eliminating Interferon (side effects in addition to the cost) will make the oral combo the dominant in the market. If the SVR is between 65-70% will be a mix, and it is less than 65% I think that the all oral may be reserved to people who can't tolerate interferon ...

    What is your guess?

95.77-1.17(-1.21%)1:57 PMEDT